drugset / Trial / NCT01316848
A Single Center, Open-label, Randomized, Two-period Crossover Food Effect Study of Single Doses of Tivozanib (AV-951) in Healthy Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
This study will determine the effect of food on the pharmacokinetics (PK) of a single dose of 1.5 mg tivozanib in normal healthy subjects.
Timeline
- Start
- 2011-02
- Primary completion
- 2011-05
- Completion
- 2011-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tivozanib | Small molecule | 1.5 mg | Oral |
Indications
No indication recorded.